Annual incidence rates of disease
|
|
|
|
Pneumococcal meningitis (<2 years)
|
0.000051
|
Base ± 25%
|
[27]
|
IPD (3-5 years)
|
0.000142
|
0.000128–0.000156
|
[28]
|
All-cause pneumonia
|
0.12815
|
Base ± 25%
|
[2]
|
All-cause AOM (≤2 years)
|
0.412
|
0.012–0.64
|
[29]
|
All-cause AOM (3-5 years)
|
0.381
|
0.012–0.64
|
[29]
|
Proportion of meningitis in IPD
|
0.3333
|
Base ± 25%
|
[30]
|
S. pneumoniae isolation rate for pneumonia
|
0.08
|
0.02–0.268
|
[31]
|
S. pneumoniae isolation rate for AOM
|
0.392
|
0.292–0.49
|
[32]
|
Disease outcomes
|
|
|
|
Case fatality rate of meningitis
|
0.083
|
Base ± 25%
|
[2]
|
Case fatality rate of bacteremia
|
0.046
|
Base ± 25%
|
[33]
|
Case fatality rate of pneumonia
|
0.00526
|
Base ± 25%
|
[2]
|
Probability of disability caused by meningitis
|
0.07
|
Base ± 25%
|
[34]
|
Probability of deafness caused by meningitis
|
0.13
|
Base ± 25%
|
[34]
|
Probability of tympanostomy caused by AOM
|
0.059
|
Base ± 25%
|
[13,35]
|
Serotype coverage rates of PCV-7
|
|
|
|
IPD
|
0.45
|
Base ± 25%
|
[27]
|
Pneumonia
|
0.763
|
Base ± 25%
|
[36]
|
AOM
|
0.648
|
Base ± 25%
|
[37]
|
Efficacy of PCV-7
|
|
|
|
IPD
|
0.974
|
Base ± 25%
|
[14]
|
Pneumonia
|
0.9
|
Base ± 25%
|
[14]
|
AOM
|
0.576
|
Base ± 25%
|
[15]
|
Relative efficacy of 2 doses
|
0.86
|
0.645–1
|
[38]
|
Relative efficacy of 3 doses
|
1
|
0.95–1
|
[24]
|
Birth cohort size in China |
16,000,000 |
- |
[39] |